Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

American Medical Marijuana Physicians Association Endorses Alternate Health's CanaPass Patient Management System

Alternate Health Corp.
Posted on: 25 Sep 17

PR Newswire

TORONTO, Sept. 25, 2017

TORONTO, Sept. 25, 2017 /PRNewswire/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, today announced that the American Medical Marijuana Physicians Association (AMMPA) has endorsed the Company's CanaPass patient management software.

"AMMPA's commitment to physician advocacy means that we are always looking for products that will help increase compliance, decrease liability, and improve patient outcomes in the medial marijuana industry," says Dr. Orlando Florete, MD, President of the American Medical Marijuana Physicians Association. "We believe that CanaPass and its U.S. equivalents will be a benefit to physicians that recommend alternative medical treatments in a safe and legal environment."

Based in Clermont, Florida, AMMPA's mission is to support physicians and patients who utilize medical marijuana as a treatment alternative in the setting of a legally indicated diagnosis. With over 650 physician members, AMMPA is a leader in providing physicians with comprehensive support in education, compliance and legal advocacy.

"We are honored to receive AMMPA's recognition of the CanaPass system's unparalleled focus on transparency and compliance," says Jade Green, Vice-President, Sales and Marketing, at Alternate Health. "This endorsement represents another step forward as we aim to set the standard in cannabis-specific medical software across North America."

The CanaPass system is a cloud-based software platform that manages the end-to-end transactions involved with providing safe access to medical cannabis for eligible patients. CanaPass's key features include the ability to view a patient's purchase history and monitor a patient's response to cannabis products, allowing physicians to make recommendation adjustments to improve overall patient outcomes.

"We are excited to see one of Alternate Health's key technology assets receiving recognition from such an influential and respected organization of physicians," says Dr. Michael Murphy, CEO of Alternate Health. "The CanaPass system solves a number of challenges in the field of medical cannabis, setting us up for new opportunities in this rapidly developing sector."

A copy of the American Medical Marijuana Physicians Association official endorsement letter can be accessed via the link below.

About Alternate Health Corp.

Alternate Health Corp. (CSE:AHG, OTCQB:AHGIF) is an international medical cannabis company that uses best in class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. The company is strategically positioned in all facets of the medical cannabis value chain through the innovative integration of proprietary technology and know-how, acquisitions and partnerships, deep direct knowledge of, and experience with improving patient outcomes, and management expertise.

Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders. The Company is headquartered in San Antonio, Texas, with operations in Los Angeles and Toronto.

For more information about Alternate Health Corp., visit

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements

SOURCE Alternate Health Corp.

PR Newswire

Last updated on: 25/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.